NCT02925130View on ClinicalTrials.gov

Beta2-mimetic and Central Nervous System

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 28, 2017

Study Completion Date

September 28, 2017

Conditions
Adrenergic Beta-2 Agonist EffectAlbuterol Effect
Interventions
DRUG

Salbutamol

Acute intake of Albuterol, a beta2-mimetic, either inhaled or oral.

DRUG

Placebo

Acute oral intake of a placebo drug

Trial Locations (1)

38042

Grenoble University Hospital, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02925130 - Beta2-mimetic and Central Nervous System | Biotech Hunter | Biotech Hunter